Moneycontrol PRO
you are here: HomeNewsOpinion

Check list for Indian pharma to remain global

The Indian government and manufacturers have to sit down together to see if more of the things that go into the final product can or need to be made in India

March 09, 2020 / 09:12 AM IST
Check list for Indian pharma to remain global

Representative image

Subir Roy India’s celebrated pharma industry faces a peculiar contradiction. There is  global concern that India’s decision to impose export restrictions to ensure domestic supplies as the corona virus infection spreads locally will lead to a worldwide shortage of key drugs when they are needed the most. The world relies heavily on India for affordable generic medicines. This is happening against the longer term backdrop of India emerging as a leading supplier of affordable essential medicines (a quarter of medicines in the...

  • PRO Panorama

    Moneycontrol Pro Panorama | It’s raining public offers and investors are spoilt for choice

    Aug 4, 2021 / 04:00 PM IST

    In today’s edition of Moneycontrol Pro Panorama: IPOs’ gale force, the capex juggernaut moves, recovery stutters, right call for Airtel, Policybazaar’s moat, the growing muscle of quants, and more

    Read Now

To read the full story, Subscribe to Moneycontrol PRO

Access the exclusive stories, weekly investment ideas and daily technical calls in an Ad free experience

Already a member? Sign in

Limited Period offer on Moneycontrol PRO. Subscribe to PRO and get up to

50% OFF

What Do You Get

  • Ad free experience

    Experience a non-intrusive navigation and faster response in the ad free mode

  • Sharpest Opinions

    Access to 230+ exclusive stories per month from our editorial and Experts

  • +

    Have a Global edge with access to content from world renowned experts and journalist

  • Actionable Insights

    Access to 40+ weekly investment ideas including 4 daily technical calls

  • Virtual Events

    Exclusive access to live webinars from market experts on trading and investment strategies

  • Newsletters

    Daily and weekly insights bundled and sent to your inbox to keep you ahead in the race.

Get upto 50% discount on limited period offers